-
Notifications
You must be signed in to change notification settings - Fork 0
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
Add: new shortform cardiology questions on arrhythmias and basics; up…
…date question indexing and filtering in the application
- Loading branch information
Showing
4 changed files
with
208 additions
and
26 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,77 @@ | ||
--- | ||
id: CARD-SF002 | ||
specialty: cardiology | ||
topic: arrhythmias | ||
difficulty: medium | ||
type: shortform | ||
tags: [cardiology, arrhythmias, ecg, emergencies, copilot] | ||
created: 2025-01-06 | ||
lastUpdated: 2025-01-06 | ||
--- | ||
|
||
# Arrhythmia Quick Questions | ||
|
||
## Question 1 | ||
Drug of choice for stable wide-complex tachycardia: | ||
A) Adenosine | ||
B) Diltiazem | ||
C) Amiodarone | ||
D) Metoprolol | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
C) Amiodarone - Safe in structural heart disease | ||
</details> | ||
|
||
## Question 2 | ||
Which finding suggests VT over SVT with aberrancy: | ||
A) Fusion beats | ||
B) RS complex >100ms | ||
C) AV dissociation | ||
D) All of the above | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
D) All of the above - Brugada criteria | ||
</details> | ||
|
||
## Question 3 | ||
Most common cause of Torsades de Pointes: | ||
A) Congenital long QT | ||
B) Drug-induced QT prolongation | ||
C) Hypokalemia | ||
D) Bradycardia | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
B) Drug-induced QT prolongation - Check QTc with risk medications | ||
</details> | ||
|
||
## Question 4 | ||
Best acute treatment for SVT with hypotension: | ||
A) Adenosine | ||
B) Synchronized cardioversion | ||
C) Metoprolol | ||
D) Diltiazem | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
B) Synchronized cardioversion - Unstable requires immediate electrical therapy | ||
</details> | ||
|
||
## Question 5 | ||
First line for rate control in AF with preserved EF: | ||
A) Digoxin | ||
B) Beta blocker | ||
C) Calcium channel blocker | ||
D) Amiodarone | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
B) Beta blocker - Most effective rate control | ||
</details> | ||
|
||
## References | ||
- ACC/AHA Guidelines 2023 | ||
- HRS Guidelines 2022 | ||
- NEJM 2021: "Management of Cardiac Arrhythmias" |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,77 @@ | ||
--- | ||
id: CARD-SF001 | ||
specialty: cardiology | ||
topic: basics | ||
difficulty: easy | ||
type: shortform | ||
tags: [cardiology, basics, ecg, pharmacology, copilot] | ||
created: 2025-01-06 | ||
lastUpdated: 2025-01-06 | ||
--- | ||
|
||
# Cardiology Quick Questions | ||
|
||
## Question 1 | ||
Which beta blocker is most cardioselective? | ||
A) Metoprolol | ||
B) Bisoprolol | ||
C) Carvedilol | ||
D) Propranolol | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
B) Bisoprolol - Highest β1 selectivity | ||
</details> | ||
|
||
## Question 2 | ||
Normal PR interval range is: | ||
A) 120-200 ms | ||
B) 80-120 ms | ||
C) 200-400 ms | ||
D) 400-600 ms | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
A) 120-200 ms - Key ECG parameter | ||
</details> | ||
|
||
## Question 3 | ||
Most specific troponin for myocardial injury: | ||
A) Troponin I | ||
B) Troponin T | ||
C) CK-MB | ||
D) Myoglobin | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
A) Troponin I - Most cardiac-specific marker | ||
</details> | ||
|
||
## Question 4 | ||
First-line treatment for stable angina: | ||
A) Nitrates | ||
B) Beta blockers | ||
C) Calcium channel blockers | ||
D) Ranolazine | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
B) Beta blockers - Reduce myocardial oxygen demand | ||
</details> | ||
|
||
## Question 5 | ||
Target INR for mechanical mitral valve: | ||
A) 2.0-2.5 | ||
B) 2.5-3.5 | ||
C) 3.0-4.0 | ||
D) 1.5-2.0 | ||
|
||
<details> | ||
<summary>Answer</summary> | ||
B) 2.5-3.5 - Higher than aortic valves | ||
</details> | ||
|
||
## References | ||
- ACC/AHA Guidelines 2023 | ||
- ESC Guidelines 2022 | ||
- NEJM 2021: "Cardiovascular Medicine Updates" |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters